FDA
approval
· 2020-11-17
FDA Approved: FULVESTRANT — Original Application (Accord Healthcare Inc.)
Summary
FDA approves Accord Healthcare's Original Application for a generic fulvestrant (Fulvestrant) for the treatment of metastatic breast cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for FULVESTRANT (FULVESTRANT)